Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (FOSUN PHARMA USA INC)

View source ↗

Summary

FDA approved a supplemental application for Prochlorperazine Edisylate by Fosun Pharma USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prochlorperazine edisylate (Prochlorperazine edisylate)

Snippet

SUPPL AP for PROCHLORPERAZINE EDISYLATE (PROCHLORPERAZINE EDISYLATE)